Nathan Stasko | Nitric Oxide Therapeutics and Innovation in Respiratory Health
Nathan Stasko joins Executive Insights for Life Sciences Innovators to discuss respiratory therapeutics, nitric oxide technology, biotechnology leadership, and the future of innovation in respiratory health.
Prefer audio only? Listen to this episode on Spotify.
Episode Overview
In this episode, Nathan Stasko discusses how Vast Therapeutics is advancing nitric oxide-based technologies for respiratory therapeutics. The conversation explores the challenges of drug development, the opportunities for innovation in respiratory health, and the leadership lessons learned while building biotechnology companies in a complex and evolving industry.
Key Themes
- Nitric oxide technology in respiratory therapeutics
- Innovation in respiratory health and disease treatment
- Drug development strategy and execution
- Biotechnology leadership and company building
- Translating scientific innovation into clinical applications
- The future of respiratory therapeutics
Why This Matters for Life Sciences Leaders
Developing innovative therapies requires leaders to navigate scientific uncertainty, clinical development challenges, and evolving market conditions. The conversation highlights how emerging respiratory technologies are advancing patient care while offering broader lessons on leadership, resilience, and strategic execution in biotechnology.
Guest Link
More from Executive Insights
Explore more conversations with life sciences founders, CEOs, investors, and operators on the Executive Insights for Life Sciences Innovators podcast.
